This study presents an intrinsic capacity clock, using blood samples to predict mortality risk and enhance understanding of ...

Guidance from Kettering Health Human Resources has been shared with leaders to help employees if their pay is incorrect. We ...

WASHINGTON — U.S. health officials on Friday endorsed the first blood test that can help diagnose Alzheimer’s and identify patients who may benefit from drugs that can modestly slow the ...

The test, developed by Fujirebio Diagnostics, measures the ratio of two proteins in the blood. The ratio is correlated with amyloid plaques in the brain—a hallmark of Alzheimer's that, until now ...

The first blood test used to diagnose Alzheimer’s disease was cleared by the Food and Drug Administration for marketing Friday, meaning the laboratory test can be marketed and sold in the U.S ...

May 16 (UPI) --The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in patients beginning to show cognitive decline. Fujirebio ...

The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that it can help reduce the need for invasive samples or expensive PET scans.

The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from a patient. “Alzheimer’s disease impacts too many people, more than ...

A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de ...